[ad_1]
The world has high hopes in advancing medical science in order to eliminate a number of incurable and deadly diseases. Because the path of science depends on accumulation, the promising medical measures that have been achieved this year require further testing, especially in the mouse during the first stage. In the case of effective treatments, academic institutions must adopt their plans to produce a drug at an appropriate price, which will ensure treatment for millions of patients around the world.
In January of this year, researchers at Stanford University announced the development of a vaccine to eliminate cancerous tumors. According to The Times Insider, a vaccine has been tested on mice with cancer, which can eliminate cancerous tumors in the animal. If this succeeds in humans, the treatment of serious illness will be easier and more effective.
Cancer chemotherapy currently affects the immune system and many patients experience serious side effects. "There is no limit to the types of tumors that this vaccine can treat," says author of the study, Ronald Levy.
In 2018, French surgeons performed an exciting "medical miracle" by performing a second facial transplant for the patient himself. The person, who was not named, had a facial transplant seven years ago, but his body refused to transplant it, which was surprising. The patient, aged about forty years, spent two months in the hospital without a face. The doctors plunged him into a coma after removing the "first face" until an appropriate donor was found for the second face. The surgery lasted a whole day and doctors would not be able to tell if the operation worked or not, a few weeks ago.
In September, Biotech Amarin announced that it had developed a drug called Vacepa, which can reduce the risk of heart attack by 25%. The FDA approved this drug in 2015, but this year's trial has proven effective in reducing some of the harmful fats in the body.
In the absence of any effective and comprehensive treatment against migraine called "sister", the FDA approved, in May 2018, the drug "Aimoving" and this treatment gave an injection a month to disable some of the molecules responsible for Pain caused by the disease.
In another development, doctors said that a Brazilian woman was born after undergoing a uterine transplant from a deceased donor, in the first successful case of its kind. Because diabetics need to pay attention to the level of glucose in the blood, the Ulsan Institute of Science and Technology, based in Korea, has developed contact lenses that can help people with the disease. The prestigious institution said in an official statement that these lenses were based on human tears to monitor the glucose level.
In May, Johnson & Johnson announced a spray model that could be used to treat depression using the drug known as ketamine for decades.
[ad_2]
Source link
